FAMILIAL ADENOMATOUS POLYPOSIS
Clinical trials for FAMILIAL ADENOMATOUS POLYPOSIS explained in plain language.
Never miss a new study
Get alerted when new FAMILIAL ADENOMATOUS POLYPOSIS trials appear
Sign up with your email to follow new studies for FAMILIAL ADENOMATOUS POLYPOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to shrink polyps in inherited colon cancer condition
Disease control TerminatedThis phase 2 trial tests whether the drug TPST-1495 can reduce the number and size of polyps in the small bowel and colon of people with familial adenomatous polyposis (FAP), an inherited condition that greatly raises colon cancer risk. About 38 participants will take the drug by…
Matched conditions: FAMILIAL ADENOMATOUS POLYPOSIS
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug E7386 tested for tough cancers
Disease control OngoingThis early-phase study tests a new drug called E7386 in about 70 people with advanced solid tumors, including colorectal cancer. The main goal is to check safety and find the right dose. Participants have tumors that no longer respond to standard treatments.
Matched conditions: FAMILIAL ADENOMATOUS POLYPOSIS
Phase: PHASE1 • Sponsor: Eisai Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC